Jonathan Bush: Why Healthcare Needs More Rule Breakers
Jonathan Bush, CEO of Zus Health, shares his vision on how artificial intelligence can transform healthcare by automating administrative tasks and why disruptive innovation is crucial in the sector.
In this interview, Jonathan Bush, CEO of Zus Health and co-founder of Athenahealth, discusses how artificial intelligence can address fundamental problems in the U.S. healthcare system, focusing on automating administrative tasks and the need to break established rules to foster innovation.
Video
Key Topics Covered
AI should not be limited to “big ideas” but used to solve everyday, repetitive problems.
The importance of automating tasks like data collection and verification to improve system efficiency.
The need for shared data platforms enabling more coordinated and accessible healthcare.
Critique of the lack of competition in the healthcare system and its impact on innovation.
The importance of leaders willing to challenge the status quo and take risks to drive change.
Highlighted Quotes
“The real opportunity lies in automating the mundane administrative work plaguing the system.”“We need more people willing to break the rules and challenge the status quo to achieve true innovation in healthcare.”
Jonathan Bush emphasizes that achieving real transformation in healthcare requires a pragmatic approach that uses technology to solve concrete, everyday problems rather than pursuing only grand innovations.
T.Rx Capital Launches $77.5M Fund I to Invest in Bold Startups at the Intersection of Technology and Biology
New venture capital firm to create and invest in early-stage healthcare companies applying novel technologies to frontier biology and redefine patient care
Article
July 12, 2025
Radiopharmaceuticals: The Next Frontier in Precision Cancer Care
Radiopharmaceuticals are emerging as the future of cancer care, combining targeted precision with powerful radiation to deliver safer, more effective treatments.
Article
May 6, 2025
New Non-Opioid Pain Medications: Redefining Relief in the Post-Opioid Era
Biotech companies are racing to develop non-opioid pain medications as safer, effective alternatives to addictive opioids, with breakthroughs like Vertex’s FDA-approved Journavx leading a new era in pain management.
Ready to Transform Healthcare?
Join us in building the future of medicine through innovative technology and biology convergence